United States · FDA National Drug Code directory
levocetirizine dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 30142-717_1a7ae26e-cc7d-442a-8308-48d31a3ade4f
- Product NDC
- 30142-717
- Form
- TABLET, COATED
- Composition / generic term
- levocetirizine dihydrochloride
- Labeler
- KROGER COMPANY
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180930
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE in 1 CARTON (30142-717-16) / 80 TABLET, COATED in 1 BOTTLE (30142-717-80) · 30142-717-16
- 1 BOTTLE in 1 CARTON (30142-717-35) / 35 TABLET, COATED in 1 BOTTLE · 30142-717-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →